Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

As good as new: why IP is central to repurposed drugs

Charlotte Kilpatrick
April 15, 2021
drug-repurpose-min.jpeg

Sources from the pharmaceutical industry explain why research organisations should learn about IP before trying to bring an approved drug to market

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Topics

IP StrategyNewsInternationalPatents
kilpatrick-charlotte-300px.png
Charlotte Kilpatrick
Reporter Managing IP
Contact
Charlotte reports on patent-related issues. She often covers the European market, focusing on developments including FRAND, licensing and trade secrets. She is particularly interested in how new technologies affect IP challenges in the pharmaceutical industry.
more from across site and ros bottom lb

More from across our site

India.jpg
India’s largest firm poaches Anand & Anand partner to kickstart IP practice
Cyril Amarchand Mangaldas has hired former Anand & Anand partner Swati Sharma and hopes to compete with specialist IP firms
Sukanya Sarkar, September 22, 2023
Documents locked with padlock and chains.
UPC denies member of the public access to pleadings
Rapporteur-Judge András Kupecz ruled that education and training weren’t legitimate reasons for a member of the public to access documents
Rory O’Neill, September 22, 2023
Employer with magnifying glass exploring application papers
Counsel: Fed Circuit design patent case decreases prior art burden
Searches for comparison prior art will be a little easier, but practitioners will have to put more thought into claim construction and design patent titles
Rani Mehta, September 22, 2023
Helsinki, Finland
UPC refuses preliminary injunction over earlier opt-out
The Helsinki local division rejected AIM Sport’s request for a preliminary injunction in a dispute with rival Supponor
Rory O’Neill, September 22, 2023
Court of Appeals Federal Circuit Lafayette Park Washington DC
This week on MIP: UPC issues first injunction, Newman ban
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Rory O’Neill, September 22, 2023
medicines
Extra Orange Book scrutiny poses questions for law firm strategy
The FTC’s plans to scrutinise improperly listed Orange Book patents could make these listings more important in litigation, but firms should be looking at this anyway
Rani Mehta, September 21, 2023
BehindtheCaseDebevoiseJPEG.jpg
Behind the case: How Debevoise got Grubhub hungry for TM victory
Counsel at Debevoise & Plimpton explain how they helped food delivery business Grubhub avoid a preliminary injunction at the Court of Appeals for the Seventh Circuit
Rani Mehta, September 21, 2023
EuropeNASA
The UPC story so far: German dominance and CMS ‘liability’ risk
European lawyers tell Managing IP how the legal market is reacting to the first few months of the UPC and why cases are set to take off
Rory O’Neill, September 21, 2023
federal-circuit-building-mw.jpg
Federal Circuit affirms one-year case ban for Newman
The ban could be extended or cancelled, depending on whether Judge Pauline Newman cooperates with an investigation, the Judicial Council of the Federal Circuit stated
Rani Mehta, September 20, 2023
move.jpg
Hard sell: lawyers struggle to move firms during China downturn
Sources say some China-based lawyers are prepared to take large pay cuts to join stable practices, but most firms are sceptical about new hires
Sukanya Sarkar, September 20, 2023